Earnings History Data for BioCryst Pharmaceuticals, Inc. (BCRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-08-2021 PM 7:00 AM ET
(Aug 5)
BCRX BioCryst Pharmaceuticals, Inc. 2,980 -0.24 -0.22 -0.24 BioCryst Pharmaceuticals EPS misses by $0.01, beats on revenue
[8/5/2021 7:06 AM]
17.64 1.38 
(8.49%)
15.70 -0.56 
(-3.44%)
3.30 - 17.81 6,903,628 2,390,000 1,323,704
06-05-2021 PM 7:00 AM ET
(May 6)
BCRX BioCryst Pharmaceuticals, Inc. 1,960 -0.36 -0.24 -0.24 BioCryst Pharmaceuticals EPS misses by $0.08, beats on revenue
[5/6/2021 7:05 AM]
12.94 2.26 
(21.16%)
12.84 -0.10 
(-0.77%)
3.30 - 14.24 17,302,298 2,540,000 43,442
25-02-2021 PM 7:00 AM ET
(Feb 25)
BCRX BioCryst Pharmaceuticals, Inc. 1,960 -0.34 -0.25 -0.02 BioCryst Pharmaceuticals EPS misses by $0.09, misses on revenue
[2/25/2021 7:11 AM]
10.50 -1.30 
(-11.05%)
11.07 -0.74 
(-6.27%)
1.58 - 12.90 6,987,657 6,620,299 459,861
05-11-2020 PM 7:00 AM ET
(Nov 5)
BCRX BioCryst Pharmaceuticals, Inc. 697.43 -0.26 -0.25 -0.34 BioCryst Pharmaceuticals EPS misses by $0.01, beats on revenue
[11/5/2020 7:04 AM]
4.24 -0.04 
(-0.82%)
4.24 0.0 
(0.00%)
1.38 - 6.29 5,662,020 4,450,424 62,520
06-08-2020 PM 7:00 AM ET
(Aug 6)
BCRX BioCryst Pharmaceuticals, Inc. 776.16 -0.24 -0.28 -0.34 BioCryst Pharmaceuticals EPS beats by $0.02, beats on revenue
[8/6/2020 7:08 AM]
4.03 -0.18 
(-4.39%)
4.01 -0.20 
(-4.75%)
1.38 - 6.29 5,862,303 6,405,615 988,592
06-05-2020 PM BCRX BioCryst Pharmaceuticals, Inc. 606.23 -0.24 -0.26 -0.28 BioCryst Pharmaceuticals EPS beats by $0.01, beats on revenue
[5/6/2020 7:03 AM]
3.95 0.02 
(0.51%)
4.02 0.07 
(1.77%)
1.38 - 8.15 12,435,959 14,352,814 276,612